These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7723357)
21. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow. Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242 [TBL] [Abstract][Full Text] [Related]
22. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043. Uretsky BF; Valdes AM; Reddy PS Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328 [TBL] [Abstract][Full Text] [Related]
23. Acute clinical benefits of a new inotropic agent AR-L 115 BS after i.v. and oral administration. el Allaf D; D'Orio V; Cremers S; Carlier J G Ital Cardiol; 1984 Oct; 14(10):830-4. PubMed ID: 6519393 [TBL] [Abstract][Full Text] [Related]
24. Hemodynamic and autonomic effects of intravenous saterinone in patients with chronic heart failure. Szabó BM; van Veldhuisen DJ; van Dijk RB; Lahiri A; Mitrovic V; Stolzenburg K; Brouwer J; Lie KI J Cardiovasc Pharmacol; 1997 May; 29(5):618-23. PubMed ID: 9213204 [TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failure. Jafri SM; Burlew BS; Goldberg AD; Rogers A; Goldstein S Am J Cardiol; 1986 Feb; 57(4):254-9. PubMed ID: 3511661 [TBL] [Abstract][Full Text] [Related]
26. [Acute hemodynamic effects of piroximone i.v. in patients with severe heart failure]. Scholz M; Kneissl GD; Winkelmann BW; Grohe G; Klittich P; Bussmann WD Z Kardiol; 1995 Oct; 84(10):827-33. PubMed ID: 7502570 [TBL] [Abstract][Full Text] [Related]
27. Five-minute recording of heart rate variability in severe chronic heart failure: correlates with right ventricular function and prognostic implications. Lucreziotti S; Gavazzi A; Scelsi L; Inserra C; Klersy C; Campana C; Ghio S; Vanoli E; Tavazzi L Am Heart J; 2000 Jun; 139(6):1088-95. PubMed ID: 10827392 [TBL] [Abstract][Full Text] [Related]
28. Hemodynamic action of nicorandil in chronic congestive heart failure. Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325 [TBL] [Abstract][Full Text] [Related]
29. Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure. Ungar A; Fumagalli S; Marini M; Di Serio C; Tarantini F; Boncinelli L; Baldereschi G; Valoti P; La Cava G; Olianti C; Masotti G; Marchionni N Crit Care Med; 2004 May; 32(5):1125-9. PubMed ID: 15190961 [TBL] [Abstract][Full Text] [Related]
30. Effect of aprindine on heart rate variability indices in patients with ischemic heart disease. Takase B; Uehata A; Nishioka T; Arakawa K; Satomura K; Ohsuzu F; Kurita A Clin Cardiol; 1999 Feb; 22(2):107-12. PubMed ID: 10068848 [TBL] [Abstract][Full Text] [Related]
31. Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure. Klauss V; Zwehl W; Mudra H; Huber R; Schmidt R; Scheininger M; Vogler A; Tschaidse O; Dieterich HA; Theisen K Klin Wochenschr; 1991 Jul; 69(10):430-5. PubMed ID: 1719270 [TBL] [Abstract][Full Text] [Related]